Genetic tests may cut insulin need

Primary care genetics society Genetics and diabetes type, response to statins and bowel disease.

Treatment of maturity onset diabetes of the young (MODY) can be significantly improved by knowing its genetic basis and some patients can even be taken off insulin.

Mark Walker, professor of molecular diabetic medicine at Newcastle University, urged GPs at the Primary Care Genetics Society conference in Newcastle last week to refer their MODY patients for genetic testing.

Distinguishing between MODY2 and MODY3, the most common types, can allow some patients to stay off therapy while protecting others by using early sulphonylurea treatment.

The gene mutations causing common forms of MODY are highly penetrant, Professor Walker said.

'The genetic heterogeneity contributes to the clinical heterogeneity and identifying the responsible gene can influence clinical management,' he said.

Patients with MODY3, the commonest form of MODY, caused by a mutation in the hepatocyte nuclear factor-1-alpha gene on chromosome 12, see rapid progression of their diabetes to insulin-dependency and have a high rate of small vessel complications. But they are hypersensitive to sulphonylureas and can react to a standard starting dose of 80mg gliclazide with hypoglycaemia.

'If a young person who is newly diagnosed, with a strong family history, does not give a full dose of sulphonylureas, assume it could be MODY,' Professor Walker said.

Fasting glucose levels are high and young people are started on insulin but can be treated with sulphonylureas, he said.

Mutations in the glucokinase gene on chromosome seven cause MODY2 in 95 per cent of patients by the age of 40 but rapid progression of the diabetes and small vessel complications are rare.

'This is a stable condition with a low risk of complications,' he said. MODY accounts for 1-3 per cent of type-2 diabetes and GPs typically have one or two patients.

Professor Walker urged referral of diabetics under 40 without ketones at diagnosis who show a strong family history and sensorineural deafness, as they might have mitochondrial diabetes.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Follow Us:

Just published

Houses of Parliament

GP partnerships 'like collapsing Jenga stack' after Javid threat to nationalise practices

Sajid Javid's decision to back a report calling for the end of the GMS contract within...

£20 notes spread out

VAT trap for PCNs could strip millions of pounds from general practice

Tens of millions of pounds could be stripped from general practice because work carried...

Talking General Practice logo

Podcast: Is the BMA representing GPs effectively, why GPs face a pension tax hit, and views on the workload crisis

In our regular news review the team discusses representation of GPs, a new survey...

Man sleeping

NICE guidance on insomnia backs app to replace sleeping pills

Hundreds of thousands of people with insomnia could be offered treatment via a mobile...

Health worker prepares a dose of COVID-19 vaccine

JCVI backs autumn COVID-19 booster campaign for high-risk adults and NHS staff

Frontline health and social care staff and adults at increased risk of severe illness...

GP consultation

Government accused of 'misleading' claims on general practice workforce

GP leaders have accused the government of making misleading claims about the general...